| pubmed-article:15531003 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15531003 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15531003 | lifeskim:mentions | umls-concept:C0027726 | lld:lifeskim |
| pubmed-article:15531003 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
| pubmed-article:15531003 | lifeskim:mentions | umls-concept:C0035363 | lld:lifeskim |
| pubmed-article:15531003 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:15531003 | pubmed:dateCreated | 2004-11-8 | lld:pubmed |
| pubmed-article:15531003 | pubmed:abstractText | Steroid-resistant nephrotic syndrome (SRNS) with focal segmental glomerulosclerosis has emerged as a leading cause of end-stage renal failure (ESRF) in children and adults. In the past decade, immunosuppressive drugs such as cyclosporine (CsA) and cyclophosphamide have been introduced for the treatment of SRNS, but data on long-term clinical outcome (over years) are lacking. | lld:pubmed |
| pubmed-article:15531003 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15531003 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15531003 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15531003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15531003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15531003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15531003 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15531003 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:15531003 | pubmed:issn | 0149-2918 | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:GhiggeriGian... | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:CarreaAlbaA | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:PerfumoFrance... | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:ScolariFrance... | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:CaridiGianluc... | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:BertelliRober... | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:CatarsiPaoloP | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:Sanna-Cherchi... | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:EmmaFrancesco... | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:CancariniGiov... | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:AllegriLandin... | lld:pubmed |
| pubmed-article:15531003 | pubmed:author | pubmed-author:RizzoniGian... | lld:pubmed |
| pubmed-article:15531003 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15531003 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:15531003 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15531003 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15531003 | pubmed:pagination | 1411-8 | lld:pubmed |
| pubmed-article:15531003 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:meshHeading | pubmed-meshheading:15531003... | lld:pubmed |
| pubmed-article:15531003 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15531003 | pubmed:articleTitle | Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study. | lld:pubmed |
| pubmed-article:15531003 | pubmed:affiliation | Department of Nephrology, G. Gaslini Children's Hospital, Genova, Italy. labnefro@ospedale-gaslini.ge.it | lld:pubmed |
| pubmed-article:15531003 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15531003 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15531003 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15531003 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15531003 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15531003 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15531003 | lld:pubmed |
